4D Molecular Therapeutics, Inc. (NASDAQ:FDMT – Get Rating) – Equities research analysts at SVB Leerink issued their Q1 2023 EPS estimates for 4D Molecular Therapeutics in a report issued on Monday, January 23rd. SVB Leerink analyst M. Foroohar forecasts that the company will post earnings of ($0.75) per share for the quarter. SVB Leerink has […]
Exchange Traded Concepts LLC increased its stake in shares of Blueprint Medicines Co. (NASDAQ:BPMC – Get Rating) by 51.6% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 661 shares of the biotechnology company’s stock after acquiring an additional 225 shares during […]
Strs Ohio Acquires 500 Shares of Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.